LexDanaLexDanabeta
New SessionDrug SearchOfficial RankingsInsights
© LexDana · beta
LexDanaLexDanabeta
New SessionDrug SearchOfficial RankingsInsights
LexDanaLexDanabeta

Insights

Analysis of patent litigation, PTAB practice, prosecution and pharma IP, written on the data behind LexDana.

AllCopyright & Trade Secrets59Federal Circuit877ITC / Section 33788Patent Litigation216Patent Prosecution126Pharma & ANDA62PTAB686Supreme Court61Trademark158USPTO Policy78Unsorted257

Tagged quarterly · clear

USPTO Policy

Patexia Patent Insight 16: U.S. Patent Grants See Mild H1 2025 Decline, But Q2 Outpaces Q1

Patent issuance trends offer valuable insight into the pace of innovation, the workload at the U.S. Patent and Trademark Office (USPTO), and the overall health of the intellectual property ecosystem. Fluctuations in annual and quarterly grant numbers can…

August 14, 2025·USPTO Policy·2 min read
Data: FDA Orange & Purple Books · prosecution & litigation metadata · read-only.